Dr. Samantha Rae Swain, MD

Dr. Swain practices at Lifovum Fertility Managment, LLC in Encino, California.

Dr. Swain's NPI, 1871938951, was assigned on May 2, 2013. Dr. Swain graduated from Lewis Katz School of Medicine in 2013. Dr. Swain holds California license A132703.

Dr. Swain's primary practice is Lifovum Fertility Managment, LLC, at 15503 W Ventura Blvd, Encino, CA 91436 in Los Angeles County. The practice phone is (818) 788-7288.

Dr. Swain's primary practice is Lifovum Fertility Managment, LLC in Encino, California. Dr. Swain is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Medical Group. Dmand AI also links Dr. Swain to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Swain practices, 3 sites in all. Vendor and product names are available with a free account.

Allergy and immunology is Dr. Swain's primary specialty in the NPI Registry, under taxonomy code 207K00000X. Dr. Swain is board certified in allergy & immunology by the American Board of Allergy and Immunology. Dr. Swain is licensed in California.

Dmand AI lists acute sinusitis, asthma, chronic nasal allergies, chronic sinusitis, hives, immune deficiency disease and upper respiratory infection (URI) among the conditions Dr. Swain treats.

CMS data shows 2,504 Medicare services from Dr. Swain across 9 procedure codes in 2024, for 199 Medicare patients. Medicare paid $43,575 for them. Every service was in an office.

CMS counts 199 Medicare patients who saw Dr. Swain in 2024. The largest group is 65 to 74, with 109 patients. 75% of them have high cholesterol, and 67% have high blood pressure. 23% are also on Medicaid. Their average risk score is 1.68, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Swain's median patient age at 49, with 68% women.

In 2024, Dr. Swain wrote 932 Medicare Part D claims for 199 patients. 66% of them were for generic drugs. CMS names the drug for 800 of them, across 17 drugs with 11 or more claims each, at $835,732 in total drug cost. In 2023, CMS named 552 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Swain for performance year 2024, reported as part of a group. Dr. Swain accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Swain as offering telehealth.

Dmand AI links 2 papers to Dr. Swain, published from 2019 to 2020. Dr. Swain's most frequent co-author is Suzanne S. Teuber, MD.

CMS Open Payments shows 5 general payments to Dr. Swain from 3 drug and device companies from 2017 to 2023. Food and beverage make up the largest share, 100% of the total. Genentech, Inc. paid the most, $125.

Dr. Swain graduated from Lewis Katz School of Medicine in 2013. Dr. Swain is a member of AAAAI and Los Angeles Society of Allergy, Asthma and Clinical Immunology.

Dr. Swain is in network with 13 carriers, including Blue Cross Blue Shield of Michigan, United Healthcare and Elevance. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.